SPCC1840.08c Antibody

What is SPCC1840.08c Antibody and what organism does it target?

SPCC1840.08c Antibody is a polyclonal antibody specifically developed for detection of the SPCC1840.08c protein in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast . This antibody is raised in rabbit using recombinant Schizosaccharomyces pombe SPCC1840.08c protein as the immunogen . The target protein has a UniProt accession number of O74481, which can be used for further reference in protein databases . As a research tool, SPCC1840.08c Antibody enables the study of protein expression and function in this model organism, which is widely used in molecular and cellular biology research.

What are the validated applications for SPCC1840.08c Antibody?

The SPCC1840.08c Antibody has been specifically tested and validated for the following applications:

These applications have been specifically tested to ensure identification of the target antigen . Unlike some other antibodies that may have broader application profiles (such as the CCDC85B antibody which is validated for WB, IHC, IF/ICC, IP, and ELISA ), the SPCC1840.08c Antibody has a more focused application range specifically for protein detection in Schizosaccharomyces pombe research contexts.

What is the proper storage protocol for SPCC1840.08c Antibody?

The SPCC1840.08c Antibody requires careful storage to maintain its activity and specificity. The recommended storage conditions are:

• Upon receipt, store at -20°C or -80°C

• Avoid repeated freeze-thaw cycles as this can degrade antibody quality

These storage recommendations align with general best practices for antibody preservation. Similar to other research antibodies, proper aliquoting upon receipt is advisable to minimize freeze-thaw cycles. The antibody is provided in a liquid form with a storage buffer containing 50% glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as a preservative .

How can optimal specificity be ensured when using SPCC1840.08c Antibody?

Ensuring specificity when working with SPCC1840.08c Antibody requires attention to several methodological factors:

The SPCC1840.08c Antibody is an antigen affinity-purified polyclonal antibody, which means it contains a heterogeneous mixture of antibodies that recognize different epitopes on the target protein . While this can provide robust signal detection, it may also introduce background in some experimental contexts. To optimize specificity:

• Include appropriate negative controls, such as:

  • Samples from related species to test cross-reactivity

  • Blocking peptide competition assays

  • Isotype controls (IgG)

• Optimize antibody dilution specifically for each experimental setup and detection method. Unlike monoclonal antibodies that tend to have more consistent dilution requirements, polyclonal antibodies like SPCC1840.08c may require empirical optimization.

• Consider pre-adsorption against related proteins if working in complex samples where cross-reactivity might be an issue.

Researchers should note that this antibody has been specifically validated for Schizosaccharomyces pombe (strain 972 / ATCC 24843) and may not show reactivity with other yeast species or more distantly related organisms .

What are the considerations for Western Blot optimization with SPCC1840.08c Antibody?

When optimizing Western Blot protocols with SPCC1840.08c Antibody, several technical considerations should be addressed:

• Sample preparation:

  • Proper cell lysis and protein extraction from S. pombe requires specialized protocols due to the robust cell wall

  • Consider spheroplasting of S. pombe cells prior to lysis, similar to methodologies used in other S. pombe protein studies

  • Include protease inhibitors to prevent degradation of the target protein

• Blocking conditions:

  • Optimization of blocking solutions (BSA vs. non-fat milk) may be necessary

  • The antibody's storage buffer contains glycerol and PBS , which may influence blocking reagent selection

• Detection system selection:

  • Choose between chemiluminescence, fluorescence, or chromogenic detection based on sensitivity requirements

  • When comparing band intensities, standardize to loading controls such as anti-α-tubulin antibody as used in other S. pombe studies

• Technical validation:

  • Consider EndoH treatment to assess glycosylation state of the target protein, which may affect antibody recognition

  • Validate bands by molecular weight comparison to the predicted size of the target protein

Unlike some antibodies with well-established dilution recommendations (like CCDC85B antibody with recommendations of 1:200-1:1000 for Western Blot ), optimal dilutions for SPCC1840.08c Antibody may need to be determined empirically for each experimental system.

How can non-specific binding be minimized when using SPCC1840.08c Antibody?

Non-specific binding is a common challenge when working with polyclonal antibodies like SPCC1840.08c. Several methodological approaches can help minimize this issue:

• Stringent washing protocols:

  • Increase washing duration and/or number of washes

  • Consider using washing buffers with slightly increased detergent concentration (0.1-0.5% Tween-20)

  • Ensure complete coverage of membranes/plates during washing steps

• Antibody dilution optimization:

  • Perform a dilution series to determine the optimal concentration that maximizes specific signal while minimizing background

  • The antibody's formulation in 50% glycerol buffer should be considered when calculating final working dilutions

• Cross-adsorption techniques:

  • Pre-incubation of diluted antibody with non-specific proteins

  • Use of commercially available blocking reagents specifically designed for polyclonal antibodies

• Buffer optimization:

  • The antibody is provided in a buffer containing 0.03% Proclin 300 and 50% glycerol in PBS (pH 7.4)

  • Consider adjusting working buffer conditions to enhance specificity while maintaining antibody stability

When comparing results with those obtained using other antibodies, researchers should be aware that detection methodologies may differ significantly, as seen in comparative studies of other antibodies like PD-L1 antibodies (SP142 and 22C3) which showed significant differences in staining patterns and sensitivities .

What controls should be included when using SPCC1840.08c Antibody?

Inclusion of appropriate controls is critical for reliable interpretation of results when using SPCC1840.08c Antibody:

• Positive controls:

  • Known samples expressing SPCC1840.08c protein

  • Recombinant SPCC1840.08c protein (similar to the immunogen used to generate the antibody)

• Negative controls:

  • Samples from knockout strains lacking SPCC1840.08c

  • Secondary antibody-only controls to assess non-specific binding of the detection system

  • Isotype control (rabbit IgG) at equivalent concentration

• Loading/technical controls:

  • Housekeeping proteins appropriate for S. pombe (such as α-tubulin)

  • Standardized protein loading verification (total protein stains)

• Specificity validation:

  • Peptide competition assays using recombinant SPCC1840.08c protein

  • Comparison with alternative detection methods (e.g., mass spectrometry) where feasible

What are the recommended approaches for quantitative analysis using SPCC1840.08c Antibody?

When using SPCC1840.08c Antibody for quantitative analysis, several methodological considerations apply:

• Standard curve generation:

  • Use purified recombinant SPCC1840.08c protein at known concentrations

  • Ensure the standard curve covers the expected range of protein expression

  • Apply appropriate curve-fitting algorithms (linear, four-parameter logistic, etc.)

• Normalization strategies:

  • Normalize to total protein concentration

  • Use internal reference proteins with stable expression in S. pombe

  • Consider the limitations of housekeeping proteins as normalizers in different experimental conditions

• Technical replication:

  • Perform at least three technical replicates for each biological sample

  • Calculate coefficients of variation to assess reproducibility

  • Exclude outliers based on pre-established statistical criteria

• Analytical considerations:

  • Define the lower limit of detection and quantification

  • Establish the dynamic range of the assay with this specific antibody

  • Account for potential hook effects at high protein concentrations

Unlike immunohistochemical scoring systems used with antibodies like 22C3 and SP142 for PD-L1 analysis , quantification with SPCC1840.08c Antibody in biochemical assays typically relies on direct signal intensity measurement rather than percentage-based scoring systems.

Can SPCC1840.08c Antibody be applied to non-standard experimental systems?

While SPCC1840.08c Antibody has been specifically validated for Schizosaccharomyces pombe (strain 972 / ATCC 24843) , researchers may consider its application in additional experimental contexts with appropriate validation:

• Alternative S. pombe strains:

  • Validation would be required for strains other than 972 / ATCC 24843

  • Sequence conservation of the target protein should be verified

  • Western blot confirmation of specificity is recommended prior to other applications

• Immunoprecipitation potential:

  • Though not explicitly validated for immunoprecipitation , polyclonal antibodies often perform well in this application

  • Optimization of binding conditions, bead selection, and elution protocols would be necessary

  • Pre-clearing samples and using appropriate negative controls becomes particularly important

• Subcellular localization studies:

  • If considering this antibody for immunofluorescence applications, extensive validation would be required

  • Fixation method optimization would be critical (alcohols, aldehydes, etc.)

  • Signal amplification systems might be necessary depending on target abundance

• Cross-species applications:

  • While not recommended without thorough validation, sequence homology analysis between S. pombe SPCC1840.08c and proteins from related species could identify potential cross-reactivity

  • Progressive epitope mapping would be beneficial for determining specificity boundaries

When expanding applications beyond those explicitly validated, researchers should follow similar rigorous validation protocols as seen in comparative antibody studies , including side-by-side testing with alternative detection methods.

What research questions can be addressed using SPCC1840.08c Antibody?

The SPCC1840.08c Antibody enables investigation of several fundamental research questions in S. pombe biology:

• Protein expression analysis:

  • Quantification of SPCC1840.08c protein levels under different growth conditions

  • Assessment of protein expression throughout the cell cycle

  • Evaluation of protein abundance in response to environmental stressors

• Protein modification studies:

  • Detection of post-translational modifications that alter protein mobility

  • Assessment of protein cleavage or degradation patterns

  • Analysis of complex formation through native condition studies

• Comparative biology:

  • Exploration of SPCC1840.08c expression compared to homologous proteins in related species

  • Investigation of evolutionary conservation of regulation mechanisms

  • Assessment of functional conservation across yeast species

• Genetic manipulation validation:

  • Confirmation of gene knockout or knockdown efficiency

  • Verification of overexpression constructs

  • Validation of epitope-tagged versions of the protein

Each of these research applications would require specific methodological optimizations and appropriate controls to ensure reliable interpretation of results obtained with the SPCC1840.08c Antibody.

How should SPCC1840.08c Antibody usage be documented in scientific publications?

Proper documentation of SPCC1840.08c Antibody usage in scientific publications should include:

• Complete antibody identification:

  • Product code: CSB-PA529185XA01SXV

  • Manufacturer: Cusabio

  • Host species: Rabbit

  • Clonality: Polyclonal

  • Target: SPCC1840.08c from Schizosaccharomyces pombe (strain 972 / ATCC 24843)

• Methodological details:

  • Working dilution used for each application

  • Incubation conditions (time, temperature, buffer composition)

  • Detection system employed

  • Validation procedures undertaken

• Control descriptions:

  • Positive and negative controls included

  • Validation of specificity in the experimental system

  • Reproducibility measures

• Data analysis parameters:

  • Quantification methods

  • Statistical approaches applied

  • Software used for image analysis

Following thorough documentation practices similar to those used in other antibody studies ensures experimental reproducibility and proper evaluation of results obtained with SPCC1840.08c Antibody.

What are the ethical considerations when using SPCC1840.08c Antibody in research?

When using SPCC1840.08c Antibody in research, ethical considerations include:

• Usage limitations:

  • The antibody is designated "For Research Use Only. Not for use in diagnostic or therapeutic procedures"

  • Results should not be directly applied to clinical contexts without appropriate translation research

• Responsible resource utilization:

  • As a made-to-order product with a lead time of 14-16 weeks , careful experimental planning is necessary to avoid waste

  • Proper storage and handling to maximize reagent lifespan

• Transparency in reporting:

  • Full disclosure of experimental limitations

  • Reporting of both positive and negative results

  • Acknowledgment of potential conflicts of interest

• Collaborative science practices:

  • Sharing of optimized protocols

  • Contribution to community knowledge about antibody performance

  • Recognition of intellectual contributions

Adhering to these ethical principles ensures responsible use of research resources and contributes to the integrity of scientific findings generated using SPCC1840.08c Antibody.